Neuroscience and drug development is thriving

We continue to see media reports describing how pharmaceutical companies are cutting or altogether halting investment in neuroscience, thereby eliminating the possibility of innovative treatments for devastating brain disorders such as depression and Alzheimer’s disease. These reports are both right and wrong. Although some pharmaceutical companies have indeed reduced spending in neuroscience, others are not only thriving, but on the cusp of making important new discoveries. It should be noted that some of the coverage is exaggerated or inaccurate. Certainly, most of it fails to report progress being made in neuroscience or the continued commitment by some pharmaceutical companies to develop innovative and potentially valuable new treatments. The negative view may stem from a report published several years ago by the European College of Neuropsychopharmacology[1], which noted that neurologic and…

Link to Full Article: Neuroscience and drug development is thriving

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!